Infectious Disease Areas CME Learning Center | Earn Free CME Credit

Filter Content

Page 1 of 6

Results 1 - 75 of 389

Am I Treating My Patients With Psoriatic Disease Effectively?

Am I Treating My Patients with Psoriatic Disease Effectively?

Strategies for Assessing and Managing DOAC-Related Bleeding

9166-0001-236x149

Reducing the Risk of Severe Illness for Patients With COVID-19

Treating Complex Cases of NTM-LD

NTM-LD Diagnosis and Management

Emerging Nonfactor Approaches for Patients with Hemophilia

ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19

9089_nsclc_titleslide

TARGET for NSCLC: Genomic Pathways and Use of EGFR Therapies

PAH: Risk Reduction Strategies Using Single and Combination Therapies

9102-chest-slides

Slides: IPF Management and Antifibrotic Therapy

9088-covid-slides

Slides: Post COVID-19 and Patients With and Without Pre-existing ILD

9088-ipf-slides

Slides: A Collaborative Approach to IPF Management

9088-sscild-slides

Slides: Practical Solutions to SSc-ILD Treatment

Improved Patient Outcomes in PAH

9088-pfild-slides8

Slides: A New Paradigm in Treating ILD

IPF Management and Antifibrotic Therapy

Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy

EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies

EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease

Updates in Diabetes Care for Primary Care Providers

Osteoporosis Updates: Primary Care’s Critical Role

Primary Care and Dyslipidemia: What Should You Do?

Staying Current in Obesity Management: Key Updates for Primary Care

Thyroid Assessment: Updates for Primary Care

A New Paradigm in Treating ILD

A Collaborative Approach to IPF Management

Practical Solutions to SSc-ILD Treatment

Post COVID-19 and Patients With and Without Pre-existing ILD

Exploring CGM: Achieving Treatment Goals Together

PAH: Aligning Treatment Strategy to Risk Level

PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes

Patient Develops de novo Features of ILD After a COVID Infection

SSc-ILD Individualized Treatment

Overlapping Symptoms and Risk Factors for COVID and IPF

Multidisciplinary Management of IPF

Fundamentals of Diagnosis: SSc-ILD

Fundamentals of Diagnosis: PF-ILD

Updates in SMA: Cure SMA Conference Coverage (CME/CE)

Beyond The Basics Of PAH

New and Emerging Options for the Management of MS

Diabetes & Nutrition

Comorbidities and Selection of DMTs

Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs

IPF Management in Practice: A Truly Interactive Experience

Conference Coverage on DMD and LGMD: Latest Developments

Management of Breakthrough Disease Activity

COVID-19 Associated ARDS

COVID-19 and Comorbid ILD

Minimizing Neurodegenerative Damage in Patients with MS

Recognizing Progressive Disease: A Challenge in the MS Clinic

Three Cases of Lung Fibrosis in Patients With COVID-19

Assessing a Patient With Long COVID-19

2021 MDA Conference Coverage

Engaging Patients with Shared Decision-Making Strategies and the Comprehensive Care Team

Advances in MS Assessment: Biomarkers and Imaging

Defining the Clinical Course of Multiple Sclerosis

Engaging the Patient in Treatment Choices

DMT Treatment Review

Nutritional Treatment Plan

Nutritional Counseling

Exploring the Evidence, the Reality, and the Potential of CGM

Key Considerations: Advances in Gene Therapy for Hemophilia

COVID-19 Acute and Long-term Lung Injury

COVID-19: An Animated Video Series

Rheumatic Learning: Next Steps for Mr. S's Established RA

Rheumatic Learning: Next Steps for Mrs. J's Early RA

Innovating Diabetes Care: Use of Real-Time Data

COVID-19 and ARDS: East Coast Experiences

Up to the Challenge: Improving T2D Outcomes with GLP-1 RAs

The Safety of Hemophilia Gene Therapy Now and in the Future

Viral Vectors Gene Therapy Podcasts

WFH Gene Therapy Registry

HTC Readiness: A Multidisciplinary Perspective

HTC Readiness: A Global Perspective

Gene Therapy: Patient Support, Patient Counseling, and Monitoring

Page 1 of 6